RXST
RxSight, Inc.−$0.21 (4.38%) At close $4.59 · Today
☾After Hours −$0.35 (7.65%) Nov 3, 7:59 PM ET
About RXST
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Cylvex Score
Multiple risk signals, limited coverage
Multi-factor score. Not a buy/sell signal.
Score history
CalibratingScore history is calibrating — it appears once enough daily scores are recorded.
What goes into the score
6 axes · equal weightThe Cylvex Score is a multi-factor summary for education. Not a buy/sell signal. Not investment advice.